MedPath

Yoga for wellness: Impact of Asana and Pranayama on Premenstrual Syndrome (PMS)

Phase 2
Registration Number
CTRI/2023/12/060710
Lead Sponsor
Anushka Pai
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

49 apparently healthy female subjects volunteering for the study.

Age group: 18 – 36 years

History of regular menstrual cycle

Females who understand English

With occurrence of PMS (According to premenstrual syndrome scale developed by Gencdogan, having total score = 80)

Exclusion Criteria

Females suffering from medical or psychiatric/somatic/ gynecological/ hormonal disorders

Females who are not using any medication or contraceptive pills

Females involved in any kind of athletic programme or practicing other forms of yogic exercises

• Female subjects who were unable to perform yoga due to any reason

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
For HRV assessment <br/ ><br>i. Time domain parameters: <br/ ><br>Mean-RR (mean of RR interval) <br/ ><br>SDNN (standard deviation [SD] of RR interval) <br/ ><br>RMSSD (the square root of the mean of the sum of the squares of the differences between adjacent NN <br/ ><br>intervals) <br/ ><br>NN50 (the number of pairs of adjacent NN intervals differing by >50 ms in the entire recording) <br/ ><br>pNN50 (the percentage of NN50 counts, given by NN50 count divided by total number of all NN intervals) <br/ ><br>ii. Frequency domain parameters: <br/ ><br>TP -Total power <br/ ><br>HF- High frequency (0.15–0.4 Hz) <br/ ><br>LF -Low frequency (0.04–0.15 Hz) <br/ ><br>LF in normalized units (LFnu) <br/ ><br>HF in normalized units (HFnu) <br/ ><br>LF/HF ratioTimepoint: T0- Baseline <br/ ><br>T1- 3 months After commencement of intervention
Secondary Outcome Measures
NameTimeMethod
Resting Heart Rate <br/ ><br>Deep Breathing Test <br/ ><br>Valsalva maneuver <br/ ><br>Isometric Handgrip test <br/ ><br>Orthostatic HypotensionTimepoint: T0- Baseline <br/ ><br>T1- 3 months After commencement of intervention
© Copyright 2025. All Rights Reserved by MedPath